Primarily engages in strategic investments in nascent businesses. Focuses capital allocation within the technology sector. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
This company is not turning a profit, so the market is pricing its sales instead: 23.4× for every dollar of annual revenue.
No analyst target is on record for this company.
The stock trades 41% below its peak. The market has trimmed its expectations for the company.
Sales run at $2.6M a year. A small number, but proof the product has real buyers.
A loss of $8.2M against $2.6M in annual sales. And on top of that, sales fell from the year before.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
We grade companies — revenue, margins, balance sheets. This is a fund, so there is no report card to give. That is not a low grade; it is a different kind of thing.
One-line summary: a basket, not a business. Judge it by what it holds.